Zhongke Jiangnan (301153) 2025 Annual Report Brief Analysis: Revenue increases but profits do not grow; the company's accounts receivable are relatively large.

According to publicly available data from Securities Star, Zhongke Jiangnan (301153) recently released its 2025 annual report. As of the end of this reporting period, the company’s total operating revenue was 827 million yuan, an increase of 0.32% year-on-year, and net profit attributable to shareholders was 101 million yuan, a decrease of 3.41% year-on-year. Looking at the quarterly data, the total operating revenue in the fourth quarter was 464 million yuan, an increase of 39.94% year-on-year, and net profit attributable to shareholders in the fourth quarter was 165 million yuan, an increase of 69.08% year-on-year. During this reporting period, Zhongke Jiangnan’s accounts receivable was quite large, with accounts receivable for the period accounting for 401.24% of the latest annual net profit attributable to shareholders.

This data is below the expectations of most analysts, who previously generally anticipated a net profit of around 201 million yuan for 2025.

The various data indicators released in this financial report performed moderately. Among them, the gross profit margin was 58.92%, a decrease of 1.37% year-on-year, the net profit margin was 12.46%, a decrease of 8.63% year-on-year, and total selling, administrative, and financial expenses amounted to 142 million yuan, accounting for 17.16% of revenue, an increase of 8.41% year-on-year. The net asset per share was 5.24 yuan, an increase of 4.5% year-on-year, the operating cash flow per share was 0.37 yuan, an increase of 44.01% year-on-year, and earnings per share were 0.29 yuan, a decrease of 3.33% year-on-year.

The financial statements provide explanations for the significant changes in financial items as follows:

1. The change in selling expenses was -5.51%, reason: reduction in share-based payment expenses.
2. The change in administrative expenses was 14.34%, reason: increase in severance benefits.
3. The change in financial expenses was 29.49%, reason: reduction in interest income.
4. The change in research and development expenses was -14.31%, reason: reduction in employee compensation and share-based payment expenses.
5. The change in cash inflows from investment activities was 815.22%, reason: increase in cash received from redeeming cash management investment products during the period.
6. The change in cash outflows from investment activities was 743.39%, reason: increase in cash paid for purchasing cash management products during the period.
7. The change in net cash flows generated from investment activities was -195.17%, reason: increase in cash paid for investments.

The Securities Star value investment circle financial report analysis tool shows:

• Business Evaluation: The company’s ROIC last year was 4.26%, indicating weak capital returns. However, the net profit margin last year was 12.46%, suggesting high added value of the company’s products or services when considering all costs. According to historical annual report data, the median ROIC since the company was listed is 24.32%, with good investment returns; the most disappointing year, 2025, had an ROIC of 4.26%, indicating average investment returns. The company’s historical financial reports have been relatively good (Note: The company has been listed for less than 10 years, and a longer listing period increases the reference significance of the financial averages).

• Debt Repayment Ability: The company’s cash assets are very healthy.

• Business Model: The company’s performance mainly relies on research and development and marketing efforts. It is necessary to carefully study the actual situation behind these driving forces.

• Business Breakdown: The company’s return on net operating assets for the past three years (2023/2024/2025) was 397.9%/143.8%/266.1%, with net operating profits of 304 million/112 million/103 million yuan, and net operating assets of 76.4163 million/78.2123 million/38.7415 million yuan.

  The company’s working capital/revenue (i.e., the funds the company needs to advance for every yuan of revenue generated during the operational process) for the past three years (2023/2024/2025) was -0.04/-0.01/-0.01, with working capital (the money the company spends during its operations) being -49.5365 million/-12.2423 million/-5.7084 million yuan, and revenue being 1.208 billion/825 million/827 million yuan.

The financial report health check tool indicates:

1. It is recommended to pay attention to the company’s accounts receivable situation (accounts receivable/profit has reached 401.24%).

The above content is compiled by Securities Star based on publicly available information and generated by AI algorithms (Internet Information Office Record No. 310104345710301240019), and does not constitute investment advice.